Case Name: KING PHARMACEUTICALS, INC. and King Pharmaceuticals Research and Development, Inc., Plaintiffs-Appellants, and Pharmaceutical IP Holding, Inc., Plaintiff-Appellant, v. SANDOZ INC., Defendant-Appellee
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2011-09-01
Citations: 428 F. App'x 988
Docket Number: No. 2011-1227
Parties: KING PHARMACEUTICALS, INC. and King Pharmaceuticals Research and Development, Inc., Plaintiffs-Appellants, and Pharmaceutical IP Holding, Inc., Plaintiff-Appellant, v. SANDOZ INC., Defendant-Appellee.
Judges: 
Reporter: West's Federal Appendix
Volume: 428
Pages: 988–988

Head Matter:
KING PHARMACEUTICALS, INC. and King Pharmaceuticals Research and Development, Inc., Plaintiffs-Appellants, and Pharmaceutical IP Holding, Inc., Plaintiff-Appellant, v. SANDOZ INC., Defendant-Appellee.
No. 2011-1227.
United States Court of Appeals, Federal Circuit.
Sept. 1, 2011.

Opinion:
ON MOTION
ORDER
The appellants move to withdraw their appeal.
Upon consideration thereof,
It Is Ordered That:
(1) The motion is granted. The appeal is dismissed.
(2) Each side shall bear its own costs.